Ultra high risk (UHR) for psychosis criteria: Are there different levels of risk for transition to psychosis?

• Published in: Schizophrenia research Vol. 125; no. 1; pp. 62 - 68
• Main Authors: Nelson, B., Yuen, K., Yung, A.R.
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier B.V 01.01.2011; Elsevier
• Subjects: Adolescent; Adult; Adult and adolescent clinical studies; Biological and medical sciences; Female; Follow-Up Studies; High risk; Humans; Male; Medical sciences; Neuropsychological Tests; Nosology. Terminology. Diagnostic criteria; Other psychotic disorders; Prodrome; Psychiatric Status Rating Scales; Psychiatric/Mental Health; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychoses; Psychosis; Psychotic Disorders - diagnosis; Psychotic Disorders - etiology; Regression Analysis; Retrospective Studies; Risk Factors; Severity of Illness Index; Techniques and methods; Time Factors; Young Adult; Australia; Oceania; Psychosis; High risk; Prodrome; Human; Social environment; Mental health; Nosology; Criterion; Follow up study; Adolescent; Young adult; Classification; Risk factor; Diagnosis; Prepsychotic state; Public health
• ISSN: 0920-9964; 1573-2509; 1573-2509
• DOI: 10.1016/j.schres.2010.10.017

The ultra high risk (UHR) for psychosis criteria have been validated in a number of studies. However, it is not known whether particular UHR criteria (Attenuated Psychotic Symptoms (APS), Brief Limited Intermittent Psychotic Symptoms (BLIPS) or Trait vulnerability criteria), or combination of criteria, is associated with a higher risk of transition to psychosis. The current study investigated this issue over a 6-month follow-up period. We hypothesised that the risk of transition would increase in the following order: Trait alone < APS alone < APS + Trait < BLIPS. Data on UHR intake criteria and transition to psychosis status at 6 months were analysed for UHR patients seen at the PACE clinic, Orygen Youth Health between January 2000 and November 2008. A total of 928 new referrals were accepted into the PACE clinic over this period of whom 817 (88%) had baseline information available for analysis. The percentage of subjects who presented with APS, Trait and BLIPS were 83%, 27% and 4%, respectively. When the two intermediate groups (APS alone and APS + Trait) were combined, there was evidence that the risk of transition increased in the order of Trait alone < APS < BLIPS ( p = 0.024, adjusted analysis). Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone < APS < BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the “early” versus “late” prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.